# Adversarial verification - osteoid_osteoma.md

1. DOSE LEAK: none. Regex scan for mg/mg-m2/AUC/Gy/mCi/q-schedules found zero matches. The only
   digit in the whole file is "12th" in the DeVita edition citation line.

2. UNGROUNDED CLAIMS: none rise to "fabricated" - the draft agent already flagged the whole file as
   non-DeVita-grounded and inline-tagged every clinical sentence "(general oncology standard, not
   from DeVita's section on this disease)", which I verified is accurate (see #3). Everything
   asserted is uncontroversial, guideline-standard orthopaedic-oncology knowledge for this entity
   (NSAIDs for prostaglandin-driven nocturnal pain, CT-guided RFA of the nidus as first-line
   definitive treatment, surgery reserved for lesions near neurovascular/spinal structures or failed
   ablation, spinal osteoid osteoma causing painful scoliosis with concave-side nidus, differential
   of osteoblastoma/Brodie abscess/osteomyelitis/Ewing sarcoma). No specific trial name, statistic,
   percentage, or drug regimen beyond generic "NSAIDs" is asserted anywhere - the draft agent
   correctly omitted recurrence-rate/success-rate numbers and ablation-modality comparisons for lack
   of a citable source. Nothing here contradicts DeVita (it simply isn't covered by DeVita).

3. CITATION: present, but honestly framed as a negative citation rather than a source claim - the
   closing line states DeVita 12th ed. by full name and explicitly says it does NOT contain a
   dedicated section on osteoid osteoma "in the text supplied for grounding," with a secondary
   mention of NCCN Guidelines for generic staging/referral conventions. No page numbers used
   anywhere (compliant). This is a materially different citation pattern than other ung5 sidecars
   that cite DeVita as the source of the content - reviewers should notice this file is admittedly
   ungrounded-in-DeVita by design, not by omission.

4. VERDICT: CLEAN (ready for R1), with the caveat that "clean" here means "no fabrication, no dose
   leak, and honest about its own lack of DeVita grounding" - not "DeVita-verified." Independently
   confirmed via grep: "osteoid osteoma" has zero hits in devita.txt; bare "osteoid" hits are all
   incidental (malignant osteoid production in osteosarcoma/chondrosarcoma chapters); "nidus" and
   "Brodie" have zero hits; "osteoblastoma" appears only twice, both as a differential-diagnosis
   name-drop, never as a management source. Recommend R1 either (a) accept as guideline-general
   content per the disease's benign/non-oncologic-behavior nature, or (b) require a dedicated
   orthopaedic-oncology/WHO Classification source to be substituted for the DeVita citation line
   before sign-off, since the current citation line names DeVita but then says DeVita doesn't cover
   it - that's honest but could read as citation-padding to a fast reader.
